Last Updated: May 27, 2026
Welcome to the AIAS website (hereinafter referred to as the “Site”). This Site is operated by AIAS (hereinafter referred to as “we,” “us,” “our,” or “AIAS”). Before you access, browse, or use this Site, or submit any inquiries, appointments, intake forms, or execute any service contracts through this Site (collectively referred to as “Services”), please read and thoroughly understand these Terms of Service (hereinafter referred to as these “Terms”).
BY ACCESSING, BROWSING, OR USING THIS SITE, OR BY CLICKING TO ACCEPT THESE TERMS WHERE THE OPTION IS PROVDIED, YOU ACKNOWLEDGE THAT YOU HAVE READ, UNDERSTOOD, AND UNCONDITIONALLY AGREE TO BE LEGALLY BOUND BY THESE TERMS AND OUR PRIVACY POLICY. IF YOU DO NOT AGREE TO ANY PART OF THESE TERMS, YOU MUST IMMEDIATELY CEASE ALL ACCESS TO THIS SITE AND REFRAIN FROM USING ANY OF OUR SERVICES.
1. Legal Limitation of Status and Scope of Services (Non-Medical Agency Declaration)
1.1 Core Identity Framework: AIAS operates strictly as an independent, third-party administrative facilitator, logistics coordinator, and consultancy provider. Our services are limited to cross-border medical travel coordination, standardization and transcription of medical records into native Chinese clinical intake formats, onshore itineraries planning, localized language translation, and logistics navigation within China. 1.2 Non-Healthcare Provider Declaration: AIAS is not a hospital, clinic, medical center, or healthcare facility, nor does it employ licensed medical practitioners or clinical professionals. AIAS holds no medical license of any nature and does not perform, provide, or deliver medical diagnoses, clinical evaluations, surgeries, pharmaceutical prescriptions, medical opinions, or active clinical care. 1.3 Nature of Website Information: All materials, data, and content published on this Site—including but not limited to descriptions of frontier medical technologies, oncological treatment methodologies, Third-Generation In Vitro Fertilization (IVF) protocols, case studies, and specialist profiles—are provided strictly for informational purposes only. Such information does not under any circumstances constitute formal medical advice, definitive clinical opinions, or a guarantee of treatment outcomes. Users must consult with a qualified, licensed physician or healthcare specialist prior to making any medical decisions.
2. Disclaimer of Clinical Risks and Third-Party Medical Liabilities (Core Defense)
2.1 Independence of Medical Performance: All active medical consultations, clinical diagnoses, prescriptions, surgical interventions, cellular therapies, and laboratory procedures are delivered entirely and independently by the licensed, Grade-3A (Tertiary Class A) Public Hospitals (or their designated International Medical Centers) in China chosen and contracted by the user. 2.2 Indemnification from Clinical Outcomes: The user explicitly acknowledges and accepts that all clinical medical interventions carry inherent risks. AIAS assumes no legal liability, joint liability, secondary liability, or financial indemnification obligations for any medical malpractice, surgical adverse events, clinical failures, post-operative complications, side effects, lack of therapeutic efficacy, deterioration of condition, or any direct or indirect bodily injury, trauma, fatality, or property damage sustained by the user during or after their treatment lifecycle within Chinese medical complexes. 2.3 Separation of Contractual Agreements: Any medical informed consent forms, surgical liability wavers, or treatment contracts executed between the user and the ultimate performing public hospital are entirely separate legal instruments. AIAS is not a party to, nor a subject of, such clinical contractual relationships.
3. Medical Documentation Transcription and Data Integrity Clauses
3.1 User Obligation of Veracity: The user bears the absolute legal obligation to ensure that all raw medical records, diagnostic reports, laboratory data, imaging scans, identity verification documents, and financial asset records provided to AIAS are 100% authentic, accurate, legally obtained, complete, and error-free. 3.2 Indemnification against Fraudulent Materials: AIAS is completely absolved of all liabilities if a user provides fraudulent, altered, or incomplete records that subsequently result in clinical intake refusal by Chinese medical boards, visa denials by consulates, entry refusals by Chinese border customs, or adverse clinical outcomes. All associated legal and financial repercussions shall be borne solely by the user. 3.3 Nature and Limitations of Medical Transcription: The translation and synthesis services provided by AIAS are strictly administrative and supplementary in nature. While we pledge to utilize personnel with background training in medical sciences, the user acknowledges that objective discrepancies exist across international medical terminology, clinical linguistic systems, and localized diagnostic standards. AIAS does not guarantee a 100% literal or absolute linguistic equivalence between translated dossiers and original foreign records. Ultimate clinical diagnostic evaluation and treatment protocol determinations rest solely on the independent professional judgment of the treating chief physicians at the Chinese receiving hospital.
4. Administrative Facilitation, Consular Protocols, and Third-Party Disclaimers
4.1 Independence of Third-Party Entities: All institutions to which AIAS connects or interfaces on behalf of the user—including but not limited to the Embassies and Consulates of the P.R.C., the National Immigration Administration of China, Chinese Visa Application Service Centers (CVASC), administrative boards of Grade-3A public hospitals, and cross-border banking institutions—operate as entirely separate, independent third-party entities. 4.2 No Guarantee of Success: All administrative reviews, immigration preparation, and coordination blueprints provided by AIAS are engineered exclusively to optimize application workflows and minimize file return risks. AIAS issues no warranty or guarantee of a “100% Visa Issuance,” “100% Hospital Invitation Letter Acquisition,” or “100% Bed/Specialist Allocation.” 4.3 Force Majeure: AIAS is fully exempt from financial compensation, damages, or service fee refunds in the event that a user’s treatment lifecycle is disrupted, delayed, or canceled due to Force Majeure events. This includes but is not limited to consular visa denials or processing delays, border entry rejections by customs authorities, hospital adjustments of clinical schedules or bed allocations driven by domestic public health mandates or emergency state decrees, or international flight cancellations.
5. Fee Separation, Cross-Border Payments, and Financial Compliance Protocols
5.1 Distinct Categorization of Costs: The user must explicitly distinguish between the following two mutually exclusive financial components:
- AIAS Service Fees: Remuneration paid directly to AIAS as consideration for administrative operations, medical file transcriptions, onshore institutional coordination, translation, and localized logistical navigation.
- Medical Treatment Fees/Deposits: Healthcare costs levied exclusively by and paid directly to the state-backed public medical complex in China administering the treatment. 5.2 Zero-Escrow & Non-Advancement Mandate: AIAS operates strictly as a service-based administrative coordinator. We do not under any circumstances handle, accept, hold, manage, or maintain escrow over user clinical funds, nor do we advance payments or deposits to medical institutions on behalf of the user. 5.3 Payment Routing Guidance & Onshore Reconciliation: The role of AIAS is strictly limited to providing legally compliant cross-border financial routing instructions, guiding the user to transfer their medical funds securely and directly into the official corporate bank account of the Chinese public hospital. Following the successful arrival of funds, AIAS case managers act as localized administrative proxies to perform the necessary in-person reconciliation at the hospital’s financial bureau and secure official fiscal receipts. AIAS assumes no legal liability for clearing delays caused by international banking networks or unexpected interventions by foreign exchange control authorities.
6. Site Content and Intellectual Property Safeguards
6.1 Proprietary Rights: All proprietary content published on this Site—including but not limited to original visa navigation manuals, analytical breakdowns of invitation letter protocols, clinical workflow charts, trade names, corporate logos, web interfaces, and proprietary operational system descriptions—is the exclusive intellectual property of AIAS and is fully protected under global intellectual property frameworks. 6.2 Strict Prohibition of Scraping and Plagiarism: Without the explicit, advance written authorization of AIAS, no individual, commercial enterprise, or competitive entity may copy, reproduce, republish, alter, adapt, distribute, or utilize automated digital scraping tools, web crawlers, or data miners to harvest content from this Site. AIAS reserves the absolute right to pursue punitive damages and injunctive relief for any intellectual property infringements.
7. Governing Law and Dispute Resolution
7.1 Applicable Law: The formation, validity, interpretation, performance, amendment, and resolution of any disputes arising out of or in connection with these Terms shall be governed exclusively by the laws of the People’s Republic of China (for the avoidance of doubt, specifically excluding the laws of the Hong Kong S.A.R., Macau S.A.R., and the Taiwan region). 7.2 Jurisdiction and Venue: Any dispute, controversy, or claim arising out of the use of this Site, these Terms, or the Services provided by AIAS shall first be subject to amicable, good-faith resolution between the parties. In the event that such negotiations fail to yield a resolution, both parties hereby irrevocably and unconditionally agree that the dispute shall be submitted to the exclusive jurisdiction of the People’s Court possessing competent territorial jurisdiction over the registered corporate domicile of AIAS, namely Guangzhou, Guangdong Province, China.